Latest News

2024 Research Travel Abstract Awards for Early Career Investigators

Presented by Pheo Para Alliance in collaboration with Neuroendocrine Tumor Research Foundation (NETRF)
Submit an abstract for consideration for the NETRF Research Symposium by June 10  here.

What: Up to two travel awards will be presented by Pheo Para Alliance to two early career investigators in the amount of $1,000 each to attend the 2024 NETRF Research Symposium on October 28-30 in Boston, MA.  These awards can be used to cover travel, hotel accommodations and other costs related to attendance at the Symposium.

Why: To reduce barriers for early career investigators to attend the NETRF Research Symposium and present their pheochromocytoma paraganglioma (pheo para) focused research and to fuel the pipeline of researchers.

Who: Eligibility includes the following:

  • Researchers must be (first or senior author) early career investigators defined as graduate or medical students, in-training post-doctoral, internal medicine residents, clinical fellows, or new faculty (hired as instructor or assistant professor within the last 3 years). Current NETRF funded grantees are not eligible.
  • Abstract submission must be focused on pheochromocytoma and/or paraganglioma and have been accepted for either oral or poster presentation at the 2024 NETRF Research Symposium.
  • Award winners agree to present their research results to the Pheo Para Alliance community virtually after the NETRF Research Symposium.

How:  Submit an abstract by June 10 through NETRF here.  All pheo para abstracts that are accepted by NETRF for an oral or poster presentation will be taken into consideration for this award.  There is no need to opt-in during the abstract submission process to be considered.

Details: Winners must be first or senior author, attend in-person, and present their poster at the NETRF Research Symposium on October 28-30 in Boston, MA.  Winners will be notified by email by mid-August.  Winners will be chosen by the Pheo Para Alliance on the basis of the quality of the abstracts’ scientific content.